A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction

被引：0
|
作者：
Kei Hosoda
Mizutomo Azuma
Chikatoshi Katada
Kenji Ishido
Masahiro Niihara
Hideki Ushiku
Mikiko Sakuraya
Marie Washio
Takuya Wada
Akinori Watanabe
Hiroki Harada
Satoshi Tanabe
Wasaburo Koizumi
Keishi Yamashita
Naoki Hiki
机构：
[1] Kitasato University School of Medicine,Department of Upper Gastrointestinal Surgery
[2] Kitasato University School of Medicine,Department of Gastroenterology
来源：
International Journal of Clinical Oncology | 2020年 / 25卷
关键词：
Locally advanced esophagogastric junction cancer; Docetaxel; Oxaliplatin; S-1; Neoadjuvant chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1090 / 1097
页数：7
相关论文
共 50 条
  • [31] Phase I study assessing the feasibility of the triple combination chemotherapy of SOXIRI (S-1/oxaliplatin/irinotecan) in patients with unresectable pancreatic ductal adenocarcinoma
    Hiroaki Yanagimoto
    Sohei Satoi
    Masayuki Sho
    Takahiro Akahori
    Tomohisa Yamamoto
    Satoshi Hirooka
    So Yamaki
    Masaya Kotsuka
    Hironori Ryota
    Shoichi Kinoshita
    Satoshi Nishiwada
    Minako Nagai
    Naoya Ikeda
    Koji Tsuta
    Yoshiyuki Nakajima
    Masanori Kon
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 35 - 41
  • [32] Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer
    Kim, Yeul Hong
    Seo, Hee Yeon
    Jeen, Yoon Tae
    Kim, Hoon-Kyo
    Shim, Byoung Yong
    Yang, Jinmo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (02) : 253 - 260
  • [33] Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer
    Yeul Hong Kim
    Hee Yeon Seo
    Yoon Tae Jeen
    Hoon-Kyo Kim
    Byoung Yong Shim
    Jinmo Yang
    Cancer Chemotherapy and Pharmacology, 2009, 63
  • [34] Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    T Takayama
    Y Sato
    T Sagawa
    T Okamoto
    H Nagashima
    Y Takahashi
    H Ohnuma
    G Kuroiwa
    K Miyanishi
    R Takimoto
    T Matsunaga
    J Kato
    K Yamaguchi
    K Hirata
    Y Niitsu
    British Journal of Cancer, 2007, 97 : 851 - 856
  • [35] Phase I study assessing the feasibility of the triple combination chemotherapy of SOXIRI (S-1/oxaliplatin/irinotecan) in patients with unresectable pancreatic ductal adenocarcinoma
    Yanagimoto, Hiroaki
    Satoi, Sohei
    Sho, Masayuki
    Akahori, Takahiro
    Yamamoto, Tomohisa
    Hirooka, Satoshi
    Yamaki, So
    Kotsuka, Masaya
    Ryota, Hironori
    Kinoshita, Shoichi
    Nishiwada, Satoshi
    Nagai, Minako
    Ikeda, Naoya
    Tsuta, Koji
    Nakajima, Yoshiyuki
    Kon, Masanori
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (01) : 35 - 41
  • [36] Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and S-1 for Resectable Advanced Esophageal Cancer
    Hayata, Keiji
    Ojima, Toshiyasu
    Nakamori, Mikihito
    Nakamura, Masaki
    Katsuda, Masahiro
    Kitadani, Junya
    Takeuchi, Akihiro
    Tabata, Hirotaka
    Maruoka, Shinpei
    Yamaue, Hiroki
    ANTICANCER RESEARCH, 2018, 38 (09) : 5267 - 5273
  • [37] A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
    Syma Iqbal
    Heinz-Josef Lenz
    David R. Gandara
    Stephen I. Shibata
    Susan Groshen
    Timothy W. Synold
    Edward M. Newman
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 85 - 91
  • [38] A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
    Iqbal, Syma
    Lenz, Heinz-Josef
    Gandara, David R.
    Shibata, Stephen I.
    Groshen, Susan
    Synold, Timothy W.
    Newman, Edward M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 85 - 91
  • [39] Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma
    Honma, Yoshitaka
    Yamada, Yasuhide
    Terazawa, Tetsuji
    Takashima, Atsuo
    Iwasa, Satoru
    Kato, Ken
    Hamaguchi, Tetsuya
    Shimada, Yasuhiro
    Ohashi, Masaki
    Morita, Shinji
    Fukagawa, Takeo
    Machida, Nozomu
    Katai, Hitoshi
    SURGERY TODAY, 2016, 46 (09) : 1076 - 1082
  • [40] Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma
    Luigi Di Lauro
    Laura Giacinti
    Maria Grazia Arena
    Domenico Sergi
    Silvia Ileana Fattoruso
    Diana Giannarelli
    Massimo Lopez
    Journal of Experimental & Clinical Cancer Research, 28
12345